Franklin Biotechnology Discovery Fund Class C (FBTDX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

151.92

+0.83 (0.55%)

At close: Oct 14, 2026

Fund Assets	1.13B
Expense Ratio	1.728%
Min. Investment	$1,000
Turnover	37.62%
Dividend (ttm)	2.62
Dividend Yield	1.72%
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Dec 22, 2025

Previous Close	151.09
YTD Return	3.00%
1-Year Return	20.66%
5-Year Return	45.77%
52-Week Low	140.38
52-Week High	189.31
Beta (5Y)	0.92
Holdings	118
Inception Date	Mar 4, 2014

About FBTDX

Franklin Biotechnology Discovery Fund Class C is an actively managed mutual fund specializing in the biotechnology sector. The fund's primary objective is capital appreciation, achieved by investing at least 80% of its net assets in equity securities of biotechnology companies and discovery research firms. It targets firms that derive at least half of their revenue from biotechnology-related activities, making it deeply focused within the life sciences industry. As a health-category fund, it offers exposure to both domestic and international companies engaged in drug development, therapeutic innovation, and related scientific advancements, with nearly half of its assets frequently concentrated in its top ten holdings across major biotech players. Since its inception in 2014, the fund has provided investors with access to a dynamic and rapidly evolving sector known for both its growth potential and volatility. Managed by Franklin Templeton Investments, the fund appeals to market participants seeking dedicated access to the biotechnology industry’s innovation cycle within the broader healthcare landscape.

Fund Family Franklin Templeton

Category Health

Performance Rating Above Average

Risk Rating Above Average

Stock Exchange Nasdaq

Ticker Symbol FBTDX

Share Class Class C

Index NASDAQ Biotechnology CR

Performance

FBTDX had a total return of 20.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.07%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
FRBRX	Class R6	0.67%
FTDZX	Advisor Class	0.76%
FBDIX	Class A	1.01%

Top 10 Holdings

36.65% of assets

Name	Symbol	Weight
Jazz Pharmaceuticals plc	JAZZ	5.06%
Amgen Inc.	AMGN	4.65%
argenx SE	ARGX	4.15%
Gilead Sciences, Inc.	GILD	4.11%
Vertex Pharmaceuticals Incorporated	VRTX	3.83%
Regeneron Pharmaceuticals, Inc.	REGN	3.74%
Revolution Medicines, Inc.	RVMD	3.13%
AstraZeneca PLC	AZN	2.72%
Ascendis Pharma A/S	ASND	2.68%
Amylyx Pharmaceuticals, Inc.	AMLX	2.57%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 22, 2025	$17.0322	Dec 22, 2025
Dec 20, 2024	$11.7607	Dec 20, 2024
Dec 15, 2021	$16.6721	Dec 15, 2021
Dec 15, 2020	$10.3921	Dec 15, 2020
Dec 16, 2019	$14.1643	Dec 18, 2019
Dec 17, 2018	$4.5496	Dec 19, 2018

Full Dividend History